WHO recommends two new drugs to treat COVID-19
Baricitinib and Sotrovimaba are recommended for patients with severe or critical COVID-19 and mild or moderate COVID-19 in patients who are at high risk of hospitalization respectively.
Recover your password.
A password will be e-mailed to you.